You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Procter & Gamble in Consumer Health

Sep 2011

Price: US$525

About this Report

About this Report

Euromonitor International's report on Procter & Gamble Co, The delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.

Company and market share data provide a detailed look at the financial position of Procter & Gamble Co, The, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Procter & Gamble Co, The This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Procter & Gamble Co, The provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

  • Scope of the Report

Strategic Evaluation

Key company facts

  • Strategic Evaluation

Sales decline but operating profit improves

  • Strategic Evaluation

SWOT: Procter & Gamble Co, The

  • Strategic Evaluation

Key objectives and challenges

  • Strategic Evaluation

P&G announces joint venture with Teva Pharmaceutical Industries

  • Strategic Evaluation

Competitive Positioning

P&G’s consumer health growth rate improves

  • Competitive Positioning

Consumer health remains fragmented

  • Competitive Positioning

Geographic and Category Opportunities

Some P&G categories to drive growth

  • Geographic and Category Opportunities

Procter & Gamble reliant on sluggish Western markets

  • Geographic and Category Opportunities

Opportunities in Key Categories

Competitive pressure in US DR affects P&G’s global OTC growth

  • Opportunities in Key Categories

Emerging countries help drive P&G’s CC&A sales growth

  • Opportunities in Key Categories

Focus on existing OTC categories and markets

  • Opportunities in Key Categories

CC&A to lead absolute growth in OTC

  • Opportunities in Key Categories

VDS to drive growth in consumer health

  • Opportunities in Key Categories

India and US help drive herbal/traditional products sales

  • Opportunities in Key Categories

Key markets drive sales growth for P&G in CSCH

  • Opportunities in Key Categories

Brand Strategy

Procter & Gamble heightens focus on core brands

  • Brand Strategy

Vicks taps into wider growth potential

  • Brand Strategy

Prilosec faces strong competition from switches in the US

  • Brand Strategy

Consumer interest in fibre-related remedies drive Metamucil sales

  • Brand Strategy

Competition in the US market affects Pepto-Bismol

  • Brand Strategy

Operations

P&G operates global distribution and manufacturing

  • Operations

P&G: emerging m arket m anufacturing s ites by country 2010

  • Operations

Recommendations

Carefully target markets to drive growth

  • Recommendations

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!